European Archives - Page 83 of 1534 - European Medical Journal

Interview: Katy Antonopoulou

My journey in patient advocacy is both personal and long-standing. I live with osteoarthritis myself, and for more than 45 years…

Abdominal Motion May Help Clear Neural Waste

New findings suggest that body movement may drive brain fluid shifts that help remove neural waste during the day.

Genomic Instability Shapes Tumour Immunity in Oesophageal Cancer

Chromosomal instability in oesophageal adenocarcinoma promotes immunosuppression and poor outcomes, revealing new therapeutic targets in tumour immune signalling.

Influenza Population Immunity Can Predict Epidemic Patterns

New study shows antibody-based population immunity measures can predict influenza subtype dominance and epidemic size across multiple countries.

Hepatitis B Virus Reactivation Risk after Rituximab Withdrawal

HBV reactivation risk increases after rituximab in lymphoma patients once antivirals stop, with most relapses occurring within the first year.

New MRI Index Improves SCD Prediction in Hypertrophic Cardiomyopathy

MRI-derived LACI improves sudden cardiac death risk prediction in hypertrophic cardiomyopathy, adding value beyond ESC guideline models.

Retraction: Sponsored Content: Optimising ▼Enfortumab Vedotin + Pembrolizumab in Comorbid Patients with Unresectable or Metastatic Urothelial Carcinoma

Optimising Hepatitis B Prophylaxis After Liver Transplantation

Despite combination prophylaxis with HBIG and NUCs transforming outcomes after liver transplantation for hepatitis B, some studies have…

Type 2 Diabetes Historically More Prevalent in Indigenous Populations

Indigenous populations historically face a significantly higher prevalence of Type 2 diabetes than global averages, a new systematic review has found.

Do Psychedelic Treatments Receive Disproportionate Media Hype?

In this study, researchers analysed 6,805 publications using natural language processing to compare sentiment and language used when discussing psychedelic treatments versus FDA-approved antidepressants.